Media Releases

For all media enquiries, please contact

Heart research to be revolutionised thanks to $8 million funding boost

Queensland researchers will begin developing a comprehensive ‘encyclopedia’ of the heart in a world-first project that, if successful, will revolutionise cardiac research and treatment.

It is one of the most ambitious cardiac research projects ever attempted and is possible thanks to an $8 million fellowship from the Snow Medical Research Foundation – a philanthropic initiative to support emerging scientists to conduct game-changing research.

The fellowship has been awarded to Associate Professor James Hudson, the head of the Cardiac Bioengineering Research Group at QIMR Berghofer Medical Research Institute.

More than one quarter (27 per cent) of all deaths in Australia in 2017 were due to cardiovascular disease, according to the Australian Institute of Health and Welfare.

Associate Professor Hudson said the development of new heart drugs had stalled worldwide and innovative new approaches were urgently needed.

“Cardiovascular disease kills more people in Australia than cancer, but the number of drugs currently being developed is about seven-fold lower,” Associate Professor Hudson said.

“At the moment we still only understand a fraction of the biology underpinning how the heart works so it’s very difficult to figure out exactly what’s going wrong. And if you don’t know what’s going wrong, you can’t fix it.

“My research will help us better understand the heart so we may address problems when they arise.”

To conduct the research, Associate Professor Hudson and his team will make 80 thousand miniature heart muscles, known as organoids.

“We know there are about 8500 genes that control heart cells, known as cardiomyocytes,” he said.

“Using tens of thousands of miniature model hearts, we will knock out those genes one at a time and see what the response is. We will then catalogue how each gene controls the biology and function of heart muscle, creating an ‘encyclopedia’.

“If we’re successful, this could be the most comprehensive database of the heart ever developed.

“We will then use machine learning to read that information and build a working biological model of heart muscle in a computer.

“Our model will allow us, for the first time, to make predictions in a computer about what’s going wrong and how to fix it, before starting the costly and time-consuming process of laboratory experiments.

“This is a new approach in biology that’s based on engineering principles. If successful, it will greatly speed up research into cardiovascular disease.

“Our vision is that in future, we will be able to plug in a patient’s transcriptome – information that tells us about a person’s genes and environment – quickly compute what is wrong with the heart, and predict with precision what treatment they should receive.

“In the shorter term, our aim is to use our system to find new targets for more effective drugs for heart failure.

“This approach has never been achieved for any organ. We hope that down the track we could also apply it to other organs.”

Associate Professor Hudson is one of three Australian researchers – along with scientists at the Australian National University and the Garvan Institute – to be awarded the Snow Medical Research Foundation’s inaugural Snow Fellowship. The highly coveted grants are each worth $1 million per year over eight years and, together, will provide a $24 million investment in medical research in Australia.

The Chair of the Snow Medical Research Foundation, Tom Snow, has congratulated Associate Professor Hudson and the other two recipients.

“The Snow family is proud to support James’s bold vision. To take on this level of risk for such a large and long-term project would not be possible with existing government grants,” Mr Snow said.

“Snow Medical is about building cross-disciplinary teams, and we were particularly attracted to James’s unique capacity to combine engineering, biochemistry and mathematics.”

“We believe that with financial backing, these three scientists will produce paradigm-shifting research that wouldn’t otherwise be possible.”

QIMR Berghofer’s Director and CEO, Professor Fabienne Mackay, applauded the Snow Medical Research Foundation’s vision and generosity.

“We are hugely grateful to Terry Snow and the Snow family for their extremely generous support in establishing and funding the Snow Fellowships,” she said.

“This is a truly visionary investment and, certainly, one of a kind in Australia. This highly ambitious program of research simply wouldn’t be possible without the guarantee of this significant funding over the next eight years.

“Associate Professor James Hudson is an emerging leader in the medical research field and Snow Medical’s support is a vote of confidence in him.

“Ultimately though, it is patients – across Australia and the world – who will benefit from Snow Medical’s generous investment in cardiac research.”


Media contacts:

Associate Professor James Hudson / QIMR Berghofer Medical Research Institute: Siobhan Barry 0458 650 200

Terry and Tom Snow/Snow Medical:  Tim Dawson 0455 227 711


About Snow Medical Research Foundation

The newly established Snow Medical Research Foundation (Snow Medical), is the creation of Canberra’s Snow family and is a vision of businessman and philanthropist, Terry Snow. Snow Medical’s pivotal program, the Snow Fellowships, targets emerging global research leaders that show the potential to drive, manage and influence the next generation of health and medical innovation. The eight year Snow Fellowship, funded at up to $1 million per year, provides outstanding biomedical researchers the independence to focus on building ambitious multidisciplinary research programs and teams capable of changing the face of healthcare in Australia and globally.

In 2020, three inaugural Snow Fellowships have been awarded. Snow Medical has also provided $5.5 million for COVID-19 research. From 2021, two Snow Fellowships will be awarded each year.

About Tom Snow

Tom Snow is Chair of the Snow Medical board and was a founder and Co-Chair of the Equality Campaign, which led and won the successful YES postal plebiscite on marriage equality. He is a Rhodes Scholar with a Masters degree in Economics and Bachelor degrees in Science and Economics (Actuarial Studies).

He is a founder of Whitehelm Capital, one of the world’s largest independent infrastructure managers with $6 billion in assets under management. As a Fellow of the Australian Institute of Company Directors, he has had roles including director of Perth Airport, Canberra Airport, Bankstown Airport, Port of Adelaide / Flinders Ports, Etihad Stadium, Peninsula Link, International Parking Group and Whitehelm Capital. Tom Snow was born and raised in Canberra and has served as chair of the Canberra Convention Bureau, chair of Equality Australia, director of the Australian Science Festival and director of the Rhodes Scholarships in Australia. He is also a proud father of three kids.

About Terry Snow

Terry Snow is the founder of Snow Medical, the Executive Chairman of Canberra Airport as well as owner of Willinga Park. In 2006, Terry was awarded an Order of Australia for his contribution to the city of Canberra, as well as for his charitable work through the Snow Foundation. In October 2009 Terry was announced as the inaugural recipient of the Canberra Business Council’s Chairman’s Award.

About Associate Professor James Hudson

Associate Professor James Hudson is the Group Leader of the Cardiac Bioengineering Research Group at QIMR Berghofer Medical Research Institute. His previous research has led to the development of human cardiac organoids that provide a model of human heart tissue in a dish. This research has also led to the discovery of biological processes that regulate cardiac biology and new drug candidates.

Associate Professor Hudson studied chemical and biological engineering before obtaining his PhD in Biotechnology at the University of Queensland in 2011. He was appointed a German Cardiology Society Fellow and completed post-doctoral studies at the University Medical Centre in Göttingen, Germany from 2011-2012. He established his own research laboratory in 2014 and moved to QIMR Berghofer in 2018. Associate Professor Hudson has received a number of prestigious awards, including the 2019 Metcalf Prize for Stem Cell Research and the Centenary Institute’s Medical Innovation Award in 2017.

About QIMR Berghofer Medical Research Institute

QIMR Berghofer is a translational research institute in Brisbane, Australia. Established in 1945, the Institute focuses on the research areas of cancer, infectious diseases, mental health and chronic disorders. QIMR Berghofer’s priority is to translate research from the laboratory bench to the hospital bedside and the broader community in order to improve human health. It does that by developing new and better prevention strategies, diagnostic tools and treatments. Based next to the Royal Brisbane and Women’s Hospital, QIMR Berghofer is home to approximately 1000 scientists, support staff and students.